Antinociceptive property of emblica officinalis gaertn (Amla) in high fat dietfed/low dose streptozotocin induced diabetic neuropathy in rats

Indian Journal of Experimental Biology

Volumn 47, Issue 9, 2009, Pages 737-742

  Kumar, N Prem ^a   Annamalai, A R ^b   Thakur, R S ^a  

^a KRUPANIDHI COLLEGE OF PHARMACY   (India)

^b ANNAMALAI UNIVERSITY   (India)

Author keywords

Antioxidant; Diabetic neuropathy; Emblica officinalis; Nociception; Oxidative stress

Indexed keywords

ANALGESIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; CATALASE; FLAVONOID; QUERCETIN; STREPTOZOCIN; SUPEROXIDE DISMUTASE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DIABETIC NEUROPATHY; DRUG EFFECT; EMBLICA OFFICINALIS; EXPERIMENTAL DIABETES MELLITUS; FAT INTAKE; GLUCOSE BLOOD LEVEL; HEAT; LIPID PEROXIDATION; MALE; METABOLISM; PAIN; RAT; SPRAGUE DAWLEY RAT;

ANALGESICS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLOOD GLUCOSE; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DIETARY FATS; FLAVONOIDS; HOT TEMPERATURE; LIPID PEROXIDATION; MALE; PAIN; PHYLLANTHUS EMBLICA; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; SUPEROXIDE DISMUTASE;

ANIMALIA; PHYLLANTHUS EMBLICA; RATTUS;

EID: 70349316885     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. (Pubitemid 29325066) Sima A A F, Sugimoto K, Experimental diabetic neuropathy: An update, Diabetologia, 42 (1999) 773.
2. Vincent, A M, Russell J W, Low P & Feldman E L, Oxidative stress in the pathogenesis of diabetic neuropathy, Endocr Rev, 25 (2004) 612.
3. Cameron N E & Cotter M A, Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes, Diabetes Res Clin Pract, 45 (1999) 137.
4. Januszewski A S, Alderson N I, Metz T O, Thorpe S R & Baynes J W, Role of lipids in chemical modification of proteins and development of complications of diabetes, Biochemical Society Transactions, 31 (2003) 1413.
5. Wright J M, Review of the symptomatic treatment of diabetic neuropathy, Pharmacotherapy, 14 (1994) 689.
6. James J L, Michael F J & Elizabeth A K, An adenosine inhibitor attenuates tactile allodynia in rats model of diabetic neuropathy, Eur J Pharmacol, 364 (1999) 141.
7. (Pubitemid 24168732) Courteix C, Bardin M, Chantelauze C, Lavarenne J & Eschalier A, Study of the sensitivity of the diabetic-induced pain model in rats to range of analgesics, Pain, 57 (1994) 153.
8. (Pubitemid 30953140) Gul H, Yildiz O, Dogrul A, Yesilyurt O & Isimer A, The interaction between IL-1beta and morphine: possible mechanisms of the deficiency of the morphine-induced analgesia in diabetic mice, Pain, 15 (2000) 39.
9. Clark J M & Lee D A, Prevention and treatment of the complications of diabetes mellitus, N Engl J Med, 332 (1995) 1210.
10. Ramaswamy S, Padmanabha P, Gopalakhrishan V, Parmar N S & Gosh M N, Analgesic effect of O- (h-hydroxy ethyl) rutoside in mice, Indian J Exp Biol, 23 (1985) 219.
11. Merken H M & Beecher G R, Measurement of food flavonoids by high performance liquid chromatography: A review, J Agri Food Chem, 48 (2000) 577.
12. Anjaneyulu M & Chopra K, Quercetin, a bioflavonoid, attenuates thermal hyperalgesia in a mouse model of diabetic neuropathic pain, Prog Neuro-Psychopharmacol Biol Psych, 27 (2003) 1001.
13. (Pubitemid 26064144) Mathur R, Sharma A, Dixit V P & Varma M, Hypolipidaemic effect of fruit juice of Emblica officinalis in cholesterol fed rabbits, J Ethnopharmacol, 50 (2) (1996) 61.
14. Jose J K & Kuttan R, Antioxidant activity of Emblica officinali, J Clin Biochem Nutr, 19 (2) (1995) 63.
15. Anila L & Vijayalakshmi N R, Beneficial effects of flavonoids from Sesamum indicum, Emblica officinalis and Momordica charantia, Phytother Res, 14 (2000) 1.
16. Tripathi S N, Tiwari C M, Upadhyay B N & Singh R S, Screening of hypoglycemic action in certain indigenous drugs, Res Ind Med Yoga Homeopathy, 14 (1979) 159.
17. Sleder J, Chen Y D I, Culli M D & Reaven G M, Hyperinsulimenia in fructose induced hypertriglycerdemia in the rat, Metabolism, 29 (1981) 303.
18. Petra M, Britta T, Macki, K & Eckart E, Flavonoid sulfates from the Convolvulaceae, Phytochemistry, 50 (1999) 267.
19. Anila L & Vijayalakshmi N R, Flavonoids from Emblica officinalis and Mangifera indica-effectiveness for dyslipidemia, J Ethnopharmacol, 79 (2002) 81.
20. (Pubitemid 41175991) Srinivasan K, Viswanad B, Asrat L, Kaul C L & Ramarao P, Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening, Pharmacol Res, 52 (2005) 313.
21. Buege J A & Aust S D, Microsomal lipid peroxidation, Methods Enzymol, 52 (1978) 302.
22. Martin J P, Assays for superoxide dismutase based on autoxidation of hematoxylin, Methods Enzymol, 186 (1990) 220.
23. (Pubitemid 30349424) Stevens M J, Obrosova I, Cao X, Huysen V C & Greene D A, Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy, Diabetes, 49 (2000) 1006.
24. Lowry O H, Rosenbrough N J, Farr A L & Randall R J, Protein measurement with folin phenol reagent, J Bio Chem, 193 (1951) 265.
25. Ellman G L, Tissue sulfhydryl groups, Arch Biochem Biophys, 82 (1959) 70.
26. Muthuraman A, Diwan V, Jaggi A S, Singh N & Singh D, Ameliorative effects of Ocimum sanctum in sciatic nerve transection-induced neuropathy in rats, J Ethnopharmacol 120 (2008) 56.
27. (Pubitemid 36693092) Sakai M, Oimomi M & Kasuga M, Experimental Studies on the Role of Fructose in the Development of Diabetic Complications, Kobe J Med Sci, 48 (5) (2002) 125.
28. Reed M J, Meszaros K & Entes L J, A new rat model of type 2 diabetes: The fat-fed, streptozotocin-treated rat, Metabolism, 49 (2000) 1390.
29. Yagihashi S, Pathology and pathogenetic mechanisms of diabetic neuropathy, Diabetes Metab Rev, 11 (1995) 193.
30. Sumner C J, Sheth, S J W & Griffin D R, Cornblath, M. Polydefkis, The spectrum of neuropathy in diabetes and impaired glucose tolerance, Neurology, 60 (2003) 108.
31. Smith A G, Russell, J E L, Feldman, J Goldstein A, Peltier S & Smith, Lifestyle intervention for pre-diabetic neuropathy, Diabetes Care, 29 (2006) 1294.
32. Ohkubo Y, Kishikawa H & Araki E, Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomized prospective 6-year study, Diabetes Res Clin Pract, 28 (1995) 103.
33. Coppey L J, Gellett J S, Davidson E P, Dunlap J A & Yorek M A, Effect of treating streptozotocin-induced diabetic rats with sorbinil, myoinositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve, Int J Exp Diabetes Res, 3 (2002) 21.
34. (Pubitemid 34066520) Autore G, Rastrelli L, Lauro M R, Marzocco S, Sorrentino R & Sorrentino U, Inhibition of nitric oxide synthase expression by a methanolic extract of Crescentia alata and its derived flavonoids, Life Sci, 70 (2001) 29.
35. (Pubitemid 36015383) Esposito K, Nappo F, Giugliano F, Giugliano G, Marfella R & Giugliano D, Effect of dietary antioxidants on postprandial endothelial dysfunction induced by a high-fat meal in healthy subjects, Am J Clin Nutr, 77 (2003) 139.
36. Van Dam P S, Van Asbeck B S, Van Oirschot J F, Biessels, G J, Hamers F P & Marx J J, Glutathione and alpha-lipoate in diabetic rats: nerve function, blood flow and oxidative state, Eur J Clin Investig, 31 (2001) 417.
37. Chan E C, Pannangpeth P & Woodman O L, Relaxation to flavones and flavonols in rat isolated thoracic aorta: Mechanism action of action and structure activity relationship, J Cardiovasc Pharmacol, 35 (2000) 326.
38. (Pubitemid 34681041) Yoshizumi M, Tsuchiya K, Suzaki Y, Kirima K, Kyaw M, Moon J H, Terao J & Tamaki T, Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway, Biochem Biophys Res Commun, 293 (2002) 458.
39. (Pubitemid 34556687) Begum A N & Terao J, Protective effect of quercetin against cigarette tar extract-induced impairment of erythrocyte deformability, J Nutr Biochem, 13 (2002) 265.
40. (Pubitemid 39077375) Janisch K M, Williamson G, Needs P & Plumb G W. Properties of quercetin conjugates: modulation of LDL oxidation and binding to human serum albumin, Free Radic Res, 38 (2004) 877.
41. (Pubitemid 34628497) Sabu M C & Kuttan R, Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property, J Ethnopharmacol, 81 (2002) 155.
42. (Pubitemid 28360240) Jeena K J, Kuttan G, Josely G & Kuttan R, Antimutagenic and anticarcinogenic activity of Emblica officinalis Gaertn, J Clin Biochem Nutr, 22 (1997) 171.
43. Kapur, D, Neuropathic pain and diabetes, Diabetes/Metab. Res. Rev, 19, (2003) S9.
44. Cameron N E, Cotter M A & Maxfield V, Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats, Diabetologia, 36 (1993) 299.